Jaguar Health (NASDAQ:JAGX) | Finanzwire

Basculer en Français

11191	Companies
247562	Keywords
175392	Articles
133786	Press releases

Home
Companies
Jaguar Health

BRIEF

published on 07/18/2024 at 16:35, 2 years 2 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Crofelemer on July 23rd

Crofelemer Webcast Jaguar Health OnTarget Trial Cancer Supportive Care
PRESS RELEASE

published on 07/18/2024 at 16:30, 2 years 2 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Jaguar Health announces webcast for cancer supportive care updates including OnTarget trial results. Make Cancer Less Shitty program expands with MCLS Ambassadors

Webcast Jaguar Health OnTarget Trial Cancer Supportive Care Make Cancer Less Shitty
BRIEF

published on 07/08/2024 at 16:35, 2 years 3 months ago

Jaguar Health Strengthens IP Protection with New European and Australian Patents

Crofelemer Jaguar Health Australian Patent European Patent SBS And CDDs
PRESS RELEASE

published on 07/08/2024 at 16:30, 2 years 3 months ago

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025

Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease

Accesswire

Published on 10/17/2026 at 03:20, 1 day 3 hours ago

Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 1 day 3 hours ago

Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 1 day 6 hours ago

Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 1 day 6 hours ago

NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 1 day 7 hours ago

Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update

View all ACCESSWIRE

EQS Group

Published on 10/17/2026 at 18:00, 12 hours 22 minutes ago

Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 17 hours 17 minutes ago

Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 17 hours 32 minutes ago

AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 1 day 10 hours ago

EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 1 day 11 hours ago

Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation

Les Echos

Published on 10/16/2026 at 18:48, 1 day 11 hours ago

Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 07:30, 1 day 22 hours ago

Third Quarter Revenues 2026
Published on 10/15/2026 at 18:50, 2 days 11 hours ago

September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 2 days 12 hours ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 17:45, 2 days 12 hours ago

VOGO : H1 2026 results.

View all LES ECHOS COMFI WIRE